Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | UNH | UNITED HEALTH GROUP INC | Healthcare | 93,600.0 | $38.9M | 3.67% | +48K | +105.7% | $415.63 | -6.8% |
| 2 | ABBV | ABBVIE INC | Healthcare | 96,775.0 | $24.4M | 2.30% | +25K | +35.2% | $251.64 | +5.3% |
| 3 | EW | EDWARDS LIFESCIENCES CORP | Healthcare | 260,000.0 | $23.5M | 2.22% | +97K | +59.5% | $90.46 | +0.6% |
| 4 | GILD | GILEAD SCIENCES INC | Healthcare | 178,250.0 | $22.5M | 2.13% | +10K | +6.3% | $126.34 | +15.3% |
| 5 | JAZZ | JAZZ PHARMACEUTICALS PLC | Healthcare | 87,440.0 | $21.1M | 1.99% | +12K | +15.2% | $240.97 | +2.6% |
| 6 | SYK | STRYKER CORPORATION | Healthcare | 65,000.0 | $20.5M | 1.93% | +17K | +36.0% | $314.84 | +7.4% |
| 7 | GKOS | GLAUKOS CORP | Healthcare | 119,000.0 | $16.6M | 1.57% | +35K | +41.7% | $139.76 | +35.2% |
| 8 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 290,500.0 | $16.6M | 1.57% | +84K | +40.3% | $57.22 | +19.3% |
| 9 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 684,250.0 | $16.6M | 1.57% | +371K | +118.3% | $24.26 | +10.4% |
| 10 | NTRA | NATERA INC | Healthcare | 61,050.0 | $16.6M | 1.56% | +9K | +18.3% | $271.45 | +21.2% |
| 11 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 139,205.0 | $16.3M | 1.54% | +47K | +50.3% | $117.07 | -16.2% |
| 12 | THC | TENET HEALTHCARE CORP | Healthcare | 85,200.0 | $15.9M | 1.50% | +31K | +57.8% | $187.08 | +46.6% |
| 13 | DHR | DANAHER CORPORATION | Healthcare | 80,252.0 | $15.3M | 1.44% | +62K | +344.6% | $190.48 | +14.4% |
| 14 | — | ANTERIS TECHNOLOGIES GLOBAL | — | 1,538,625.0 | $15.2M | 1.43% | +100K | +7.0% | $9.85 | — |
| 15 | PNTG | PENNANT GROUP INC | Healthcare | 371,471.0 | $13.7M | 1.30% | +96K | +34.9% | $36.95 | +5.9% |
| 16 | ELV | ELEVANCE HEALTH INC | Healthcare | 34,900.0 | $13.5M | 1.27% | +3K | +8.1% | $386.73 | +2.8% |
| 17 | LIVN | LIVANOVA PLC | Healthcare | 164,000.0 | $13.5M | 1.27% | +9K | +5.8% | $82.23 | -4.4% |
| 18 | CRL | CHARLES RIV LABS INTL INC | Healthcare | 57,200.0 | $13.0M | 1.22% | +31K | +120.0% | $226.79 | +31.2% |
| 19 | IDYA | IDEAYA Biosciences Inc | Healthcare | 343,800.0 | $12.8M | 1.21% | +88K | +34.6% | $37.27 | +2.4% |
| 20 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 560,250.0 | $12.2M | 1.16% | +181K | +47.7% | $21.86 | -9.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.4%